Research factors | Number of studies | Heterogeneity test | Effect model | Pooled OR (95%CI) | Pooled p value | ||
---|---|---|---|---|---|---|---|
Q | I2 (%) | P | |||||
Septicemia | 25 | 43.43 | 45 | 0.009 | Fixed effect | 3.91 (3.37, 4.55) | < 0.001 |
Blood transfusion | 13 | 23.68 | 49 | 0.02 | Fixed effect | 2.41 (1.97, 2.95) | < 0.001 |
Neonatal asphyxia | 14 | 23.58 | 45 | 0.04 | Fixed effect | 2.46 (2.07, 2.93) | < 0.001 |
Pneumonia | 6 | 1.34 | 0 | 0.93 | Fixed effect | 6.17 (3.98, 9.57) | < 0.001 |
Infection occurs | 2 | 1.43 | 30 | 0.23 | Fixed effect | 5.99 (2.57, 13.93) | < 0.001 |
Oral probiotics | 17 | 96.90 | 83 | < 0.001 | Random effect | 0.36 (0.25, 0.53) | < 0.001 |
Breastfeeding | 13 | 302.01 | 96 | < 0.001 | Random effect | 0.31 (0.16, 0.62) | < 0.001 |
Congenital heart disease | 3 | 2.01 | 1 | 0.37 | Fixed effect | 4.80 (3.00, 7.68) | < 0.001 |
Intrahepatic cholestasis of pregnancy | 4 | 2.17 | 0 | 0.54 | Fixed effect | 2.71 (1.92, 3.82) | < 0.001 |
Mechanical ventilation | 4 | 0.68 | 0 | 0.88 | Fixed effect | 1.44 (1.22, 1.71) | < 0.001 |
Gestational diabetes | 2 | 0.06 | 0 | 0.80 | Fixed effect | 3.08 (1.73, 5.48) | 0.0001 |
Respiratory distress syndrome | 4 | 1.24 | 0 | 0.74 | Fixed effect | 3.28 (2.23, 4.85) | < 0.001 |
Prenatal application of glucocorticoids | 5 | 6.19 | 35 | 0.19 | Fixed effect | 0.38 (0.24, 0.60) | < 0.001 |
Intravenous Immunoglobulin | 2 | 5.46 | 82 | 0.02 | Random effect | 0.70 (0.10, 5.20) | 0.73 |
Hypoalbuminemia | 2 | 0.43 | 0 | 0.51 | Fixed effect | 2.80 (1.78, 4.41) | < 0.001 |
Patent ductus arteriosus | 3 | 0.28 | 0 | 0.87 | Fixed effect | 3.10 (1.93, 4.98) | < 0.001 |
respiratory failure | 2 | 3.50 | 71 | 0.06 | Random effect | 7.51 (1.60, 35.10) | 0.01 |
Severe anemia | 4 | 2.02 | 0 | 0.57 | Fixed effect | 2.86 (2.06, 3.99) | < 0.001 |
History of antibiotic use | 2 | 4.53 | 78 | 0.03 | Random effect | 2.12 (1.18, 3.81) | 0.01 |
Meconium-stained amniotic fluid | 2 | 0.05 | 0 | 0.82 | Fixed effect | 3.14 (1.64, 6.01) | < 0.001 |